ROLL, PETRA ; OSTERMEIER, EVA ; HAUBITZ, MARION ; LOVRIC, SVJETLANA ; UNGER, LEONORE ; HOLLE, JULIA ; KÖTTER, INA ; HENES, JÖRG C. ; BERGNER, RAOUL 
; RUBBERT-ROTH, ANDREA ; SPECKER, CHRISTOF ; SCHULZE-KOOPS, HENDRIK ; MÜLLER-LADNER, ULF ; FLECK, MARTIN ; BURMESTER, GERD-RÜDIGER ; HIEPE, FALK ; HEITMANN, STEFAN ; ARINGER, MARTIN ; FISCHER-BETZ, REBECCA ; DÖRNER, THOMAS ; TONY, HANS-PETER
; RUBBERT-ROTH, ANDREA ; SPECKER, CHRISTOF ; SCHULZE-KOOPS, HENDRIK ; MÜLLER-LADNER, ULF ; FLECK, MARTIN ; BURMESTER, GERD-RÜDIGER ; HIEPE, FALK ; HEITMANN, STEFAN ; ARINGER, MARTIN ; FISCHER-BETZ, REBECCA ; DÖRNER, THOMAS ; TONY, HANS-PETER 
Zusammenfassung
Objective. Rituximab (RTX) therapy is a treatment option in patients with refractory antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We investigated the tolerability and clinical efficacy of RTX in a cohort of patients with refractory AAV. Methods. Clinical and safety data of patients with AAV treated with RTX were retrospectively assessed from the data of a German ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric